Prospect News: News for Ache Laboratorios Farmaceuticos SA

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with A > Issuers starting with A, EM only > All stories on Ache Laboratorios Farmaceuticos SA > Stories on Ache Laboratorios Farmaceuticos SA, EM only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Ache Laboratorios Farmaceuticos SA

1/18/2024	EM	Fitch changes Ache Laboratorios view
7/28/2023	EM	Fitch raises Numerous Brazilian corporates
5/7/2020	EM	Fitch revises views on several Brazilian corporates
12/12/2019	EM	S&P goes positive on 30 Brazilian companies
2/27/2018	EM	Fitch lowers Brazilian corporates
1/12/2018	EM	S&P acts on Brazilian corporates
5/11/2016	BKEMHYIG	Fitch acts on various Brazilian corporates
12/17/2015	EM	Moody’s cuts Growthpoint view to negative
12/17/2015	EM	Fitch lowers several Brazil companies
1/24/2013	EM	Fitch lifts Ache Laboratories
2/6/2012	EM	Fitch rates Ache BBB-

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.